August 2022
Heba Mansour > Other Awards
- Neuroscience cover competition winner, International Brain Research Organization (IBRO), 2021
https://www.sciencedirect.com/journal/neuroscience/about/news#2022-neuroscience-cover-competition-winner
Full Member
Dr Heba Mansour
Membership since:
2026
Field of activity:
Degrees:
Publications resulting from Research
List of publications (2021-2025)
Edited Books
1-Receptor Tyrosine kinases in Neurodegenerative and Psychiatric disorders, 1st edition, 2023
Heba Mansour, Mahmoud Khattab, Aiman El-Khatib; Editors
Elsevier publisher, Academic Press, (11 chapters), NJ, USA, June 2023.
https://shop.elsevier.com/books/receptor-tyrosine-kinases-in-neurodegenerative-and-psychiatric-disorders/mansour/978-0-443-18677-6
ISBN: 978-0-443-18677-6
2-Regulated cell death in Neurodegenerative disorders, 1st edition, 2025
Heba Mansour, Aiman El-Khatib; Editors
Elsevier publisher, Academic Press, (14 chapters), NJ, USA, July 2025
https://www.sciencedirect.com/book/9780443328527/regulated-cell-death-in-neurodegenerative-disorders#book-info
3-Protein Serine/Threonine Kinases in Neurodegenerative
disorders 1st edition, 2026
Heba Mansour, Aiman El-Khatib; Editors
Elsevier publisher, Academic Press, (26 chapters), NJ, USA (Expected publication date: July 2026).
1-Lapatinib ditosylate rescues memory impairment in D-galactose/ovariectomized rats: Potential repositioning of an anti-cancer drug for the treatment of Alzheimer's disease. Heba M. Mansour, Hala M. Fawzy, Aiman S. El-Khatib, and Mahmoud M. Khattab* Experimental Neurology Journal, Volume 341, 2021,113697, ISSN 0014-4886, https://doi.org/10.1016/j.expneurol.2021.113697 . "One of the most popular articles on social media according to PlumX metrics".
2-Potential Repositioning of Anti-cancer EGFR Inhibitors in Alzheimer’s Disease: Current Perspectives and Challenging Prospects. Heba M. Mansour*, Hala M. Fawzy, Aiman S. El-Khatib, and Mahmoud M. Khattab. Neuroscience, Volume 469, 2021, Pages 191-196, ISSN 0306-4522, https://doi.org/10.1016/j.neuroscience.2021.06.013.
3-Inhibition of mitochondrial pyruvate carrier 1 by lapatinib ditosylate mitigates Alzheimer's-like disease in D-galactose/ovariectomized rats. Heba M. Mansour*, Hala M. Fawzy, Aiman S. El-Khatib, and Mahmoud M. Khattab. Neurochemistry International, Volume 150, 2021, 105178, ISSN 0197-0186, https://doi.org/10.1016/j.neuint.2021.105178.
4-Repurposed anti-cancer epidermal growth factor receptor inhibitors: mechanisms of neuroprotective effects in Alzheimer’s disease Heba M. Mansour, Hala M. Fawzy, Aiman S. El-Khatib, and Mahmoud M. Khattab*. Neural Regeneration Research 17(9):p 1913-1918, September 2022, https://doi.org/10.4103/1673-5374.332132.
5- Can anti-cancer drugs be used as an effective therapy for the treatment of Alzheimer’s disease? Heba M. Mansour*, Aiman S. El-Khatib, and Mahmoud M. Khattab. Research Outreach magazine, 2022. https://researchoutreach.org/community-content/can-anti-cancer-drugs-be-used-as-an-effective-therapy-for-the-treatment-of-alzheimers-disease/
6- Chapter 1-Nutrition and Brain Functions in Health and Disease Heba M. Mansour. In: Mohamed, W., Kobeissy, F. (eds) Nutrition and Psychiatric Disorders. Nutritional Neurosciences. Springer, Singapore, 2022. https://doi.org/10.1007/978-981-19-5021-6_1
7- Chapter 15-Nutrition and Psychiatric Disorders: Focus on Schizophrenia. Heba M. Mansour. In: Mohamed, W., Kobeissy, F. (eds) Nutrition and Psychiatric Disorders. Nutritional Neurosciences. Springer, Singapore, 2022. https://doi.org/10.1007/978-981-19-5021-6_15
8- Kinases control of regulated cell death revealing druggable targets for Parkinson’s disease, Heba M. Mansour*, Ahmed F. Mohamed, Aiman S. El-Khatib, Mahmoud.M. Khattab, Ageing Research Reviews, Volume 85, 2023, 101841, ISSN 1568-1637, https://doi.org/10.1016/j.arr.2022.101841.
9- Chapter 10 - Repositioning of receptor tyrosine kinase inhibitors: from cancer to neurodegenerative and psychiatric disorders, Heba M. Mansour*, Aiman S. El-Khatib, Editor(s): Heba Mohamed Mansour, Mahmoud Mohamed Khattab, Aiman Saad El-khatib, Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders, Academic Press, 2023, https://doi.org/10.1016/B978-0-443-18677-6.00010-5.
10- Edited book- Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders, Academic Press, Heba Mohamed Mansour, Mahmoud Mohamed Khattab, Aiman Saad El-khatib, 2023, https://doi.org/10.1016/C2021-0-03296-X.
11- Lapatinib ditosylate rescues motor deficits in rotenone-intoxicated rats: Potential repurposing of anti-cancer drug as a disease-modifying agent in Parkinson's disease, Heba M. Mansour, Ahmed F. Mohamed, Aiman S. El-Khatib, Mahmoud.M. Khattab, European Journal of Pharmacology, Volume 954, 2023, 175875, ISSN 0014-2999, https://doi.org/10.1016/j.ejphar.2023.175875.
12- Pazopanib ameliorates rotenone-induced Parkinsonism in rats by suppressing multiple regulated cell death mechanisms, Heba M. Mansour, Ahmed F. Mohamed, Aiman S. El-Khatib, Mahmoud.M. Khattab, Food and Chemical Toxicology, Volume 181, 2023, 114069, ISSN 0278-6915, https://doi.org/10.1016/j.fct.2023.114069.
13- Exploring Parkinson-associated kinases for CRISPR/Cas9-based gene editing: beyond alpha-synuclein, Heba M. Mansour*, Aiman S. El-Khatib, Ageing Research Reviews, Volume 92, 2023, 102114, ISSN 1568-1637, https://doi.org/10.1016/j.arr.2023.102114.
14- Heat Shock Protein 90 in Parkinson’s Disease: Profile of a Serial Killer, Heba M. Mansour*, Ahmed F. Mohamed, Mahmoud.M. Khattab, Aiman S. El-Khatib, Neuroscience, Volume 537, 2024, Pages 32-46, ISSN 0306-4522, https://doi.org/10.1016/j.neuroscience.2023.11.031.
15- The interference between SARS-COV-2 and Alzheimer’s disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic, Heba M. Mansour, Ageing Research Reviews, Volume 94, 2024, 102195, ISSN 1568-1637, https://doi.org/10.1016/j.arr.2024.102195.
16- Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation of dopamine D3 receptor, Heba M. Mansour, Ahmed F. Mohamed, Mahmoud. M. Khattab, Aiman S. El-Khatib, Brain Research, Volume 1834, 2024, 148893, ISSN 0006-8993, https://doi.org/10.1016/j.brainres.2024.148893.
17- Chapter 15- From Ideation to Innovation: Integrating Pharmaceutical Innovation and Sustainable Development, Heba M. Mansour*, Aiman S. El-Khatib, Editor(s): Pranav Kumar Prabhakar, Walter Leal Filho, Preserving Health, Preserving Earth, The Path to Sustainable Healthcare, The Path to Sustainable Healthcare, Springer, Singapore, 2024, https://link.springer.com/chapter/10.1007/978-3-031-60545-1_15
18- Chapter 2-Therapeutic strategies for combating reactive oxygen species in cardiovascular diseases, Heba M. Mansour*, Editor(s): Ali Hussein Eid, Firas Kobeissy, Ahmed F. El-Yazbi, Oxidative Stress in Cardiovascular-Metabolic Diseases, Oxidative Stress in Applied Basic
Research and Clinical Practice book series, Springer, Singapore, 2024, https://link.springer.com/chapter/10.1007/978-3-031-62131-4_2
19- Review article- Oligonucleotide-Based Therapeutics for Neurodegenerative Disorders: Focus on Antisense Oligonucleotides. Heba M. Mansour*, Aiman S. El-Khatib, European Journal of Pharmacology, Volume 998, 2025, 177529, ISSN 0014-2999, https://doi.org/10.1016/j.ejphar.2025.177529
20- Book chapter (CH.10)-Navigating the Kinases Landscape: Impact on Regulated Cell Death mechanisms in Neurodegenerative disorders, Heba M. Mansour*, Aiman S. El-Khatib, Editor(s): Heba M. Mansour, Aiman S. El-Khatib, Regulated cell death in neurodegenerative disorders, Academic Press, Elsevier, 2025
https://doi.org/10.1016/B978-0-443-32852-7.00003-6
21-Regulatory Book Chapter, Ch22-Innovation through Renovation: Navigating Regulatory Framework and Technical Challenges of Drug Repositioning., Heba M. Mansour, Aiman S. El-Khatib, Stacey Ayres, William F. Salminen, Talyor and Francis, (Accepted chapter), Expected date of publication: 26-December 2025
----------------------------------------------------------------------------------------------------------
Edited Books
1-Receptor Tyrosine kinases in Neurodegenerative and Psychiatric disorders, 1st edition, 2023
Heba Mansour, Mahmoud Khattab, Aiman El-Khatib; Editors
Elsevier publisher, Academic Press, (11 chapters), NJ, USA, June 2023.
https://shop.elsevier.com/books/receptor-tyrosine-kinases-in-neurodegenerative-and-psychiatric-disorders/mansour/978-0-443-18677-6
ISBN: 978-0-443-18677-6
2-Regulated cell death in Neurodegenerative disorders, 1st edition, 2025
Heba Mansour, Aiman El-Khatib; Editors
Elsevier publisher, Academic Press, (14 chapters), NJ, USA, July 2025
https://www.sciencedirect.com/book/9780443328527/regulated-cell-death-in-neurodegenerative-disorders#book-info
3-Protein Serine/Threonine Kinases in Neurodegenerative
disorders 1st edition, 2026
Heba Mansour, Aiman El-Khatib; Editors
Elsevier publisher, Academic Press, (26 chapters), NJ, USA (Expected publication date: July 2026).
1-Lapatinib ditosylate rescues memory impairment in D-galactose/ovariectomized rats: Potential repositioning of an anti-cancer drug for the treatment of Alzheimer's disease. Heba M. Mansour, Hala M. Fawzy, Aiman S. El-Khatib, and Mahmoud M. Khattab* Experimental Neurology Journal, Volume 341, 2021,113697, ISSN 0014-4886, https://doi.org/10.1016/j.expneurol.2021.113697 . "One of the most popular articles on social media according to PlumX metrics".
2-Potential Repositioning of Anti-cancer EGFR Inhibitors in Alzheimer’s Disease: Current Perspectives and Challenging Prospects. Heba M. Mansour*, Hala M. Fawzy, Aiman S. El-Khatib, and Mahmoud M. Khattab. Neuroscience, Volume 469, 2021, Pages 191-196, ISSN 0306-4522, https://doi.org/10.1016/j.neuroscience.2021.06.013.
3-Inhibition of mitochondrial pyruvate carrier 1 by lapatinib ditosylate mitigates Alzheimer's-like disease in D-galactose/ovariectomized rats. Heba M. Mansour*, Hala M. Fawzy, Aiman S. El-Khatib, and Mahmoud M. Khattab. Neurochemistry International, Volume 150, 2021, 105178, ISSN 0197-0186, https://doi.org/10.1016/j.neuint.2021.105178.
4-Repurposed anti-cancer epidermal growth factor receptor inhibitors: mechanisms of neuroprotective effects in Alzheimer’s disease Heba M. Mansour, Hala M. Fawzy, Aiman S. El-Khatib, and Mahmoud M. Khattab*. Neural Regeneration Research 17(9):p 1913-1918, September 2022, https://doi.org/10.4103/1673-5374.332132.
5- Can anti-cancer drugs be used as an effective therapy for the treatment of Alzheimer’s disease? Heba M. Mansour*, Aiman S. El-Khatib, and Mahmoud M. Khattab. Research Outreach magazine, 2022. https://researchoutreach.org/community-content/can-anti-cancer-drugs-be-used-as-an-effective-therapy-for-the-treatment-of-alzheimers-disease/
6- Chapter 1-Nutrition and Brain Functions in Health and Disease Heba M. Mansour. In: Mohamed, W., Kobeissy, F. (eds) Nutrition and Psychiatric Disorders. Nutritional Neurosciences. Springer, Singapore, 2022. https://doi.org/10.1007/978-981-19-5021-6_1
7- Chapter 15-Nutrition and Psychiatric Disorders: Focus on Schizophrenia. Heba M. Mansour. In: Mohamed, W., Kobeissy, F. (eds) Nutrition and Psychiatric Disorders. Nutritional Neurosciences. Springer, Singapore, 2022. https://doi.org/10.1007/978-981-19-5021-6_15
8- Kinases control of regulated cell death revealing druggable targets for Parkinson’s disease, Heba M. Mansour*, Ahmed F. Mohamed, Aiman S. El-Khatib, Mahmoud.M. Khattab, Ageing Research Reviews, Volume 85, 2023, 101841, ISSN 1568-1637, https://doi.org/10.1016/j.arr.2022.101841.
9- Chapter 10 - Repositioning of receptor tyrosine kinase inhibitors: from cancer to neurodegenerative and psychiatric disorders, Heba M. Mansour*, Aiman S. El-Khatib, Editor(s): Heba Mohamed Mansour, Mahmoud Mohamed Khattab, Aiman Saad El-khatib, Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders, Academic Press, 2023, https://doi.org/10.1016/B978-0-443-18677-6.00010-5.
10- Edited book- Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders, Academic Press, Heba Mohamed Mansour, Mahmoud Mohamed Khattab, Aiman Saad El-khatib, 2023, https://doi.org/10.1016/C2021-0-03296-X.
11- Lapatinib ditosylate rescues motor deficits in rotenone-intoxicated rats: Potential repurposing of anti-cancer drug as a disease-modifying agent in Parkinson's disease, Heba M. Mansour, Ahmed F. Mohamed, Aiman S. El-Khatib, Mahmoud.M. Khattab, European Journal of Pharmacology, Volume 954, 2023, 175875, ISSN 0014-2999, https://doi.org/10.1016/j.ejphar.2023.175875.
12- Pazopanib ameliorates rotenone-induced Parkinsonism in rats by suppressing multiple regulated cell death mechanisms, Heba M. Mansour, Ahmed F. Mohamed, Aiman S. El-Khatib, Mahmoud.M. Khattab, Food and Chemical Toxicology, Volume 181, 2023, 114069, ISSN 0278-6915, https://doi.org/10.1016/j.fct.2023.114069.
13- Exploring Parkinson-associated kinases for CRISPR/Cas9-based gene editing: beyond alpha-synuclein, Heba M. Mansour*, Aiman S. El-Khatib, Ageing Research Reviews, Volume 92, 2023, 102114, ISSN 1568-1637, https://doi.org/10.1016/j.arr.2023.102114.
14- Heat Shock Protein 90 in Parkinson’s Disease: Profile of a Serial Killer, Heba M. Mansour*, Ahmed F. Mohamed, Mahmoud.M. Khattab, Aiman S. El-Khatib, Neuroscience, Volume 537, 2024, Pages 32-46, ISSN 0306-4522, https://doi.org/10.1016/j.neuroscience.2023.11.031.
15- The interference between SARS-COV-2 and Alzheimer’s disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic, Heba M. Mansour, Ageing Research Reviews, Volume 94, 2024, 102195, ISSN 1568-1637, https://doi.org/10.1016/j.arr.2024.102195.
16- Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation of dopamine D3 receptor, Heba M. Mansour, Ahmed F. Mohamed, Mahmoud. M. Khattab, Aiman S. El-Khatib, Brain Research, Volume 1834, 2024, 148893, ISSN 0006-8993, https://doi.org/10.1016/j.brainres.2024.148893.
17- Chapter 15- From Ideation to Innovation: Integrating Pharmaceutical Innovation and Sustainable Development, Heba M. Mansour*, Aiman S. El-Khatib, Editor(s): Pranav Kumar Prabhakar, Walter Leal Filho, Preserving Health, Preserving Earth, The Path to Sustainable Healthcare, The Path to Sustainable Healthcare, Springer, Singapore, 2024, https://link.springer.com/chapter/10.1007/978-3-031-60545-1_15
18- Chapter 2-Therapeutic strategies for combating reactive oxygen species in cardiovascular diseases, Heba M. Mansour*, Editor(s): Ali Hussein Eid, Firas Kobeissy, Ahmed F. El-Yazbi, Oxidative Stress in Cardiovascular-Metabolic Diseases, Oxidative Stress in Applied Basic
Research and Clinical Practice book series, Springer, Singapore, 2024, https://link.springer.com/chapter/10.1007/978-3-031-62131-4_2
19- Review article- Oligonucleotide-Based Therapeutics for Neurodegenerative Disorders: Focus on Antisense Oligonucleotides. Heba M. Mansour*, Aiman S. El-Khatib, European Journal of Pharmacology, Volume 998, 2025, 177529, ISSN 0014-2999, https://doi.org/10.1016/j.ejphar.2025.177529
20- Book chapter (CH.10)-Navigating the Kinases Landscape: Impact on Regulated Cell Death mechanisms in Neurodegenerative disorders, Heba M. Mansour*, Aiman S. El-Khatib, Editor(s): Heba M. Mansour, Aiman S. El-Khatib, Regulated cell death in neurodegenerative disorders, Academic Press, Elsevier, 2025
https://doi.org/10.1016/B978-0-443-32852-7.00003-6
21-Regulatory Book Chapter, Ch22-Innovation through Renovation: Navigating Regulatory Framework and Technical Challenges of Drug Repositioning., Heba M. Mansour, Aiman S. El-Khatib, Stacey Ayres, William F. Salminen, Talyor and Francis, (Accepted chapter), Expected date of publication: 26-December 2025
----------------------------------------------------------------------------------------------------------